Autolus Therapeutics (AUTL) Interest & Investment Income (2017 - 2025)
Historic Interest & Investment Income for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $4.4 million.
- Autolus Therapeutics' Interest & Investment Income fell 4733.17% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.2 million, marking a year-over-year decrease of 1690.25%. This contributed to the annual value of $32.4 million for FY2024, which is 13957.79% up from last year.
- Per Autolus Therapeutics' latest filing, its Interest & Investment Income stood at $4.4 million for Q3 2025, which was down 4733.17% from $5.2 million recorded in Q2 2025.
- Autolus Therapeutics' Interest & Investment Income's 5-year high stood at $28.0 million during Q3 2021, with a 5-year trough of $28000.0 in Q1 2022.
- Over the past 5 years, Autolus Therapeutics' median Interest & Investment Income value was $3.4 million (recorded in 2023), while the average stood at $4.8 million.
- In the last 5 years, Autolus Therapeutics' Interest & Investment Income soared by 7557567.57% in 2021 and then tumbled by 9941.07% in 2022.
- Autolus Therapeutics' Interest & Investment Income (Quarter) stood at $149000.0 in 2021, then surged by 857.05% to $1.4 million in 2022, then soared by 111.08% to $3.0 million in 2023, then surged by 147.41% to $7.4 million in 2024, then crashed by 41.16% to $4.4 million in 2025.
- Its Interest & Investment Income was $4.4 million in Q3 2025, compared to $5.2 million in Q2 2025 and $6.1 million in Q1 2025.